Miguel Zubizarreta, CEO, and Robert Arch, President of Immunophotonics, Inc. are gearing up for a presentation with exciting updates at the BIO Investment & Growth Summit, taking place March 2–3, 2026, at the Eden Roc Miami Beach Hotel.

Miguel and Robert look forward to connecting with investors and industry peers as they showcase Immunophotonics’ pioneering efforts in Interventional Immuno‑Oncology® with focus on our lead molecule, IP-001. This innovative approach is designed to stimulate anti-tumor immune responses following injection after routine local tumor ablation therapies and prevent cancer from coming back – one of the most significant unmet needs in cancer care today.

We are excited to meet investors, industry leaders, and peers to discuss the future of Immuno-Oncology!